Below is a list of grant and award recipients. You may narrow the list down by using the filters below. The list can be sorted by year, last name, and institution. The institution listed reflects the sponsoring institution at the time of grant or award.
Past Recipients Year First Name Last Name Degree Institution Title Grant Amount ($) Subject Area
2019 Kelly Chien MD, BS The University of Texas M.D. Anderson Cancer Center Patterns of leukemic transformation in patients with TP53-mutant myelodysplastic syndromes.
2019 Dai Chihara MD, PhD National Cancer Institute Randomized phase II study of cladribine with simultaneous or delayed rituximab in patients with untreated hairy cell leukemia.
2019 Anusha Chimmiri MS National Cancer Centre Singapore A novel computational OMICS and non-OMICS approach for identifying true pathogenic risk variants for Asian prostate cancer.
2019 Hyun-Jeung Choi PhD NGeneBio Validation and utilization of NGS-based HEMEaccuTest panel and analysis software for hematological malignancies.
2019 Andrew Chow MD, PhD Memorial Sloan Kettering Cancer Center Assessment of Tim-4+ Pleural Macrophages as Negative Regulators of Anti-Tumor T Cell Immunity in Lung Cancer 50,000.00 Lung Cancer
2019 Victor Chow MD University of Washington Acalabrutinib in combination with anti-CD19 Chimeric antigen receptor T-cells (CART) in B-cell lymphoma 50,000.00 Lymphoma and Plasma Cell Disorders
2019 Mudit Chowdhary MD Rush University Medical Center Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity and trunk soft tissue sarcoma?
2019 Kaitlin Christopherson MD The University of Texas M.D. Anderson Cancer Center Improving quality through A.I.: Applying machine learning to predict unplanned hospitalizations after radiation.
2019 William Chu MD, FRCP, MSc University of Toronto A phase I study of MR-HIFU hyperthermia (HT) with radiation (RT) and chemotherapy (CT) for recurrent rectal cancer.
2019 Lauren Colbert MD The University of Texas M.D. Anderson Cancer Center Use of Radiomic Characteristics associated with Decreased T-Cell Response to predict In-Field Failure after Definitive Chemoradiation for Anal Squamous Cell Carcinoma 50,000.00 Radiation Oncology
2019 Julie Collins MD, MPH National Cancer Institute Phase I trial of a modified vaccinia ankara (MVA) priming vaccine followed by a fowlpox virus (FPV) boosting vaccine modified to express brachyury and costimulatory molecules in advanced solid tumors.
2019 Vincenza Conteduca MD, PhD Dana-Farber Cancer Institute SLFN11 expression (exp) in castration-resistant prostate cancer (CRPC) patients (pts) predicts response to platinum-based chemotherapy (PLT).
2019 Pippa Cosper MD, PhD University of Wisconsin Chromosomal instability as a potential mechanism and marker of radiation sensitivity in head and neck cancer 50,000.00 Head & Neck Cancer
2019 Agnieszka Cseh MD Boehringer-Ingelheim Afatinib as a novel potential treatment option for NRG1 fusion-positive tumors.
2019 Colleen Cuthbert PhD University of Calgary Patient level factors associated with chronic opioid use in cancer patients.
2019 Matthew Dallos MD Columbia University Medical Center Maximizing androgen deprivation immunogenicity through PD-1 and IL-8 blockade in castration-sensitive prostate cancer 50,000.00 Genitourinary Cancer
2019 Shaheenah Dawood FACP, FRCP Mediclinic City Hospital Development of a telegenetics program in the Asia-Pacific/Middle East region.
2019 Zoneddy Dayao MD University of New Mexico Building a survivorship care plan delivery process: Experience in an academic center.
2019 Manon de Vries-Brilland MSc Integrated Centers of Oncology (ICO) Are immune checkpoint inhibitors (ICI) a valid option for papillary renal cell carcinoma (pRCC)? A multicenter retrospective study.
2019 Antonio Di Meglio MD Institut Gustave Roussy Impact of overweight, obesity and post-treatment weight changes on occupational reintegration of breast cancer (BC) survivors.
2019 Brunella Di Stefano MD Fondazione Policlinico Universitario A. Gemelli-IRCCS-UOC Oncologia Medica Clinical, pathological and prognostic features of rare BRAF mutations (MTs) in metastatic colorectal cancer (mCRC): A bi-institutional retrospective analysis (REBUS study).
2019 Elizabeth Ding Harvard Medical School CancerScreen: A novel ultrasensitive liquid biopsy for early-stage cancer detection by ctDNA Duplex Sequencing and Tissue of Origin identification with supervised machine learning.
2019 Stephanie Dixon MD, BS St. Jude Children's Research Hospital Chronic health conditions (CHC) and late mortality in survivors of acute lymphoblastic leukemia (ALL) in the Childhood Cancer Survivor Study.
2019 Nazli Dizman MD City of Hope Infigratinib in upper tract urothelial carcinoma vs urothelial carcinoma of the bladder and association with comprehensive genomic profiling/cell-free DNA results.
2019 Deborah Doroshow MD, PhD Yale University Targeting DNA Damage Repair Mechanisms in IDH1/2 Mutated Intrahepatic Cholangiocarcinomas and Other Solid Tumors 50,000.00 Developmental Therapeutics - Experimental Therapeutics
2019 Shaan Dudani MBChB University of Calgary First-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Preliminary results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
2019 Narjust Duma MD Mayo Clinic Evaluating unconscious bias: Speaker introductions at an international oncology conference.
2019 Jeffrey Edwards Other Stanford University
2019 Ista Egbeto Other Tufts University School of Medicine
2019 Yasir Elamin MD The University of Texas M.D. Anderson Cancer Center Optimizing targeted therapy for HER2 mutant non-small cell lung cancer (NSCLC) and other solid tumors 200,000.00 Lung Cancer
2019 Lawson Eng MD Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre Impact of health behavior change on health utility (HU) and financial toxicity in head and neck cancer (HNC) survivors.
2019 Temidayo Fadelu MD, MPH Dana-Farber Cancer Institute Mobile Health intervention to reduce treatment care-continuum delays among breast cancer patients in Rwanda. 50,000.00 Breast Cancer
2019 Taimy Falcon-Rodriguez MD San Juan Bautista School of Medicine
2019 Zachary Farmer MD Levine Cancer Institute Comprehensive geriatric assessment in lung cancer and hematologic malignancy.
2019 Kelly Faulk MD University of Colorado Assessment of enrollment characteristics for Children’s Oncology Group (COG) upfront therapeutic clinical trials 2004-2015.
2019 Sophie Feng MBBS Princess Margaret Cancer Centre, Canada Evaluating the value of checkpoint inhibitor therapy using the ASCO and ESMO frameworks.
2019 Roberto Ferrara MD Istituto Nazionale dei Tumori Fast-progression (FP), hyper-progression (HPD) and early deaths (ED) in advanced non-small cell lung cancer (NSCLC) patients (pts) upon PD-(L)-1 blockade (IO).
2019 Arlindo Ferreira MD, MSc Institut Gustave Roussy Differential impact of endocrine therapy (ET) and chemotherapy (CT) on quality of life (QoL) of 4,262 breast cancer (BC) survivors: A prospective patient-reported outcomes (PRO) analysis.
2019 Stefanie Fischer MD University of Manchester Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.
2019 Charalampos Floudas MD, DMSc, MS National Cancer Institute Combined immune checkpoint inhibition (ICI) with tremelimumab and durvalumab in patients with advanced hepatocellular carcinoma (HCC) or biliary tract carcinomas (BTC).
2019 Adriana Fonseca MD The Hospital for Sick Children Outcome of children with malignant germ cell tumors by response status at the end of induction chemotherapy.
2019 Elisa Fontana MD The Institute of Cancer Research and The Royal Marsden Hospital Characterisation of chemoradiation-induced changes in immune cells and targets for personalized therapy in locally advanced rectal cancer (LARC).
2019 Deborah Forst MD Massachusetts General Hospital Psychological Intervention for Caregivers of Patients with Malignant Gliomas 200,000.00 Central Nervous System Tumors
2019 Jason Frankel MD Virginia Mason Medical Center Contemporary trends in treatment for low-risk prostate cancer.
2019 MARIA FRANZOI MD Hospital de Clinicas de Porto Alegre
2019 Christi French PhD, BS Digital Reasoning Automate incidental findings in radiology reports using natural language processing and machine learning to identify and classify lung nodules.
2019 Kentaro Fukushima MD Shinshu University School of Medicine Impact of adjuvant chemotherapy using gemcitabine plus S-1 after surgical resection for advanced biliary cancer.
2019 Jacquelyne Gaddy MD University at Buffalo 1,500.00
2019 Adam Gadzinski MD, MS University of Washington Telehealth to improve access to urological cancer care among rural patients 50,000.00 Genitourinary Cancer
2019 Adriana Gamboa MD Emory University Duodenal neuroendocrine tumors: Somewhere between the pancreas and small bowel?